Concepedia

Maxi Zumpe

MZ

Statistics

Publications

11

Citations

318

H-Index

11

Active since

2016

Affiliations

Universitätsmedizin Greifswald(Current)

St Anna Children's Hospital

Apeiron Biologics (Austria)

Maxi Zumpe is an author at Universitätsmedizin Greifswald specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

2016–2023

11

Publications

11

PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD<sub>2</sub> antibody ch14.18/CHO

Nikolai Siebert, Maxi Zumpe, Madlen Jüttner et al. · OncoImmunology · 2017 · 63 citations · Full text

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Nikolai Siebert, Christin Eger, Diana Seidel et al. · mAbs · 2016 · 56 citations · Full text

Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer et al. · OncoImmunology · 2016 · 55 citations · Full text

GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma

Sascha Marx, Fabian Wilken, Isabel Viola Wagner et al. · Journal of Neuro-Oncology · 2020 · 24 citations

, , +11

Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study

Holger N. Lode, Karoline Ehlert, Stephanie Huber et al. · British Journal of Cancer · 2023 · 21 citations · Full text

1–5 of 11